2. Academic Validation
  3. ACSL3 and ACSL4, Distinct Roles in Ferroptosis and Cancers

ACSL3 and ACSL4, Distinct Roles in Ferroptosis and Cancers

  • Cancers (Basel). 2022 Nov 29;14(23):5896. doi: 10.3390/cancers14235896.
Yufei Yang 1,  Ting Zhu 2,  Xu Wang 2,  Fen Xiong 1,  Zhangmin Hu 1,  Xuehan Qiao 1,  Xiao Yuan 2,  Deqiang Wang 1 3
Affiliations

Affiliations

  • 1 Department of Medical Oncology, Affiliated Hospital of Jiangsu University, Zhenjiang 212001, China.
  • 2 Institute of Oncology, Affiliated Hospital of Jiangsu University, Zhenjiang 212001, China.
  • 3 Institute of Digestive Diseases, Jiangsu University, Zhenjiang 212001, China.
PMID: 36497375 DOI: 10.3390/cancers14235896
Abstract

The long-chain fatty acyl CoA synthetase (ACSLs) family of Enzymes contributes significantly to lipid metabolism and produces acyl-coenzyme A by catalyzing fatty acid oxidation. The dysregulation of ACSL3 and ACSL4, which belong to the five isoforms of ACSLs, plays a key role in Cancer initiation, development, metastasis, and tumor immunity and may provide several possible therapeutic strategies. Moreover, ACSL3 and ACSL4 are crucial for Ferroptosis, a non-apoptotic cell death triggered by the accumulation of membrane lipid peroxides due to iron overload. Here, we present a summary of the current knowledge on ACSL3 and ACSL4 and their functions in various cancers. Research on the molecular mechanisms involved in the regulation of Ferroptosis is critical to developing targeted therapies for Cancer.

Keywords

ACSL3; ACSL4; cancer; ferroptosis.

Figures